IRF2 and non-small cell lung carcinoma: IRF-2 promotes malignant behaviors including glycolysis, cell proliferation, and cell cycle arrest in nasopharyngeal cancer [19]; IRF-2 can also induce cell apoptosis and repress cell proliferation and migration ability in non-small cell lung cancer [20, 21].